Sorry, you need to enable JavaScript to visit this website.

A Study To Test PF-04449913 (Glasdegib) With Intensive or Non-Intensive Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

A Phase 1b/2 Study to Evaluate the Safety and Efficacy of PF-04449913, an Oral Hedgehog Inhibitor, in Combination With Intensive Chemotherapy, Low Dose Ara-C or Decitabine in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Category & Conditions: Cancer
Medicine: DAURISMO TABLETS(GLASDEGIB) Identifier (NCT): NCT01546038
Protocol ID: B1371003
Open Plain Language Summary Result: Click here